Potential applications and human biosafety of nanomaterials used in nanomedicine
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
With the rapid development of nanotechnology, potential applications of nanomaterials in medicine have been widely researched in recent years. Nanomaterials themselves can be used as image agents or therapeutic drugs, and for drug and gene delivery, biological devices, nanoelectronic biosensors or molecular nanotechnology. As the composition, morphology, chemical properties, implant sites as well as potential applications become more and more complex, human biosafety of nanomaterials for clinical use has become a major concern. If nanoparticles accumulate in the human body or interact with the body molecules or chemical components, health risks may also occur. Accordingly, the unique chemical and physical properties, potential applications in medical fields, as well as human biosafety in clinical trials are reviewed in this study. Finally, this article tries to give some suggestions for future work in nanomedicine research. Copyright © 2017 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–228 of 228
Skopalík, J., Poláková, K., Havrdová, M., Justan, I., Magro, M., Milde, D., Knopfová, L., Šmarda, J., Polakova, H., Gabrielová, E., et al. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s66986 · Cited by 44 · cited 2×
“Other properties unique among NPs include surface plasmon resonance in some metal particles and superparamagnetism in magnetic materials (Chen et al., 2015d; Estelrich et al., 2015; Hussein-Al-Ali et al., 2014; Skopalik et al., 2014), which makes them desirable as a magnetictargeting tool for medical applications.”
Ko, A. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s88084 · Cited by 42
Mease, P. J. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq285 · Cited by 40
Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes
Goldfine, A. B., Fonseca, V. A., Jones, M. R., Wang, A. C., Ford, D. M., & Truitt, K. E. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1241195 · Cited by 40
Chen, B., Guo, L., Zhang, H., Wang, F., Liu, P., Wang, Y., Xia, G., Liu, R., Li, X., yin, H., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s85587 · Cited by 40 · cited 2×
“…polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011; Chavez-Santoscoy et al., 2012), polymeric (Guo et al., 2015b; Vicente et al., 2013), chitosan (Danesh-Bahreini et al., 2011; Doavi et al., 2016; Hunsawong et al., 2015) and silica NPs (Mahony…”
Self-citationNano-Targeted Delivery of Toremifene, an Estrogen Receptor-α Blocker in Prostate Cancer
Hariri, W., Sudha, T., Bharali, D. J., Cui, H., & Mousa, S. A. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1662-x · Cited by 40 · cited 1×
“Nanomaterials have many other applications in the field of nanomedicine, such as NPs encapsulating hormone drugs (Ayano et al., 2012; Hariri et al., 2015; Ishihara et al., 2009a,b; Santander-Ortega et al., 2009; Silva J. Appl.”
nab-Paclitaxel dose and schedule in breast cancer
Martín, M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0587-y · Cited by 37 · cited 1×
“Subsequently, a number of clinical trials have examined different schedules, doses, and combinations in an effort to optimize nab-paclitaxel-based therapy for metastatic and early stage breast cancer (Martin, 2015).”
Webster, T. J., Yao, C., Hedrick, Pareek, Haleblian, & Renzulli (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s44901 · Cited by 36 · cited 1×
“Yao et al. (2013) investigated the nanostructured polyurethane and poly-lacticco-glycolic acid scaffolds in an in vivo study, and found that nanostructured polyurethane and poly-lactic-co-glycolic acid composites could significantly increase bladder tissue repair.”
Fabrication of Silk Fibroin/P(LLA‐CL) Aligned Nanofibrous Scaffolds for Nerve Tissue Engineering
Zhang, K., Wu, J., Huang, C., & Mo, X. (2012) · Macromolecular Materials and Engineering · doi:10.1002/mame.201200038 · Cited by 36 · cited 2×
“2018; 38: 3–24Copyright © 2017 John Wiley & Sons, Ltd.wileyonlinelibrary.com/journal/jat 4 diffusivity, lower sintering temperature and sintering shrinkage than large ones (Zhang et al., 2013a).”
Nanocarriers, nanovaccines, and nanobacteria as nanobiotechnological concerns in modern vaccines
Gill, P. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.1016/j.scient.2013.05.012 · Cited by 34 · cited 2×
“Nanomaterials can be used for nanovaccines including natural nanocarriers (i.e. as bacterial spores, virus-like particles, exosomes and bacteriophages) and synthetic nanocarriers (i.e. proteosomes, liposomes, virosomes, SuperFluids and nanobeads) (Gill, 2013).”
Toxicology of engineered nanomaterials - a review of carcinogenic potential.
Tsuda, H., Xu, J., Sakai, Y., Futakuchi, M., & Fukamachi, K. (2009) · PubMed · Cited by 33
Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging
Cao, Z., Zhang, C., Zhu, W., Xu, M. T., Feng, S., Xie, X., Jiang, Q. Y., Liu, J., & Wang, W. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s66919 · Cited by 32 · cited 3×
“Nanomaterials have been investigated in the medical field for drugs (Cao et al., 2014; Ranganathan et al., 2012; Tan et al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al.”
Diagnosis of prostate cancer via nanotechnological approach
Lee, K. H., Kang, B. J., Jeun, M., Jang, G. H., Song, S. H., Jeong, I. G., Kim, C., & Searson, P. C. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91908 · Cited by 31 · cited 2×
“, 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging (Cao et al.”
A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system
Singh, S. R., Tiwari, P. M., Waffo, Miller, Vig, K., Dennis, V. A., & Eroğlu, E. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43168 · Cited by 30 · cited 2×
“, 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al.”
Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors
Polyak, D., Krivitsky, A., Scomparin, A., Eliyahu, S., Kalinski, H., Avkin-Nachum, S., & Satchi‐Fainaro, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.034 · Cited by 29 · cited 1×
“Polyak et al. (2016) tried using systemic delivery of siRNA by another novel nanocarrier, aminated poly(α) glutamate, for the treatment of solid tumors in an ovarian adenocarcinoma-bearing mice model.”
Shao, C., Liu, F., Le, W., Mei, T., Wang, T., Chen, L., Lei, Y., Cui, S., Chen, B., & Cui, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104501 · Cited by 29
Margel, S., Kolitz‐Domb, M., Corem‐Salkmon, E., & Grinberg, I. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s68582 · Cited by 25
Chou, C., Chen, Y., Liou, G., Pan, H., Tseng, H., & Hung, Y. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s86592 · Cited by 22 · cited 5×
“Other properties unique among NPs include surface plasmon resonance in some metal particles and superparamagnetism in magnetic materials (Chen et al., 2015d; Estelrich et al., 2015; Hussein-Al-Ali et al., 2014; Skopalik et al., 2014), which makes them desirable as a magnetictargeting tool for…”
InfluentialJi, A., Liu, X., Xu, Q., Wu, P., Zuo, X., Zhang, J., Deng, H., Wu, Z., & Liu, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s63717 · Cited by 21 · cited 1×
“…(Cao et al., 2014; Ranganathan et al., 2012; Tan et al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et al., 2014; Wang et al., 2013), gene therapy (Rodriguez-Gascon…”
Imaging intracellular and systemicin vivogold nanoparticles to enhance radiotherapy
Botchway, S. W., Coulter, J. A., & Currell, F. J. (2015) · British Journal of Radiology · doi:10.1259/bjr.20150170 · Cited by 21 · cited 2×
“At present, the most commonly investigated nanoparticulate radiosensitizers in preclinical models include gold (Botchway et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015;…”
Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide
Chen, P., Chen, B., Ran, P., & Askhatova, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s79306 · Cited by 19 · cited 4×
“Chen et al. (2015b) designed a photoacoustic nanoprobe for pH detection.”
InfluentialDrug development in anaesthesia: industrial perspective
Kilpatrick, G. J., & Tilbrook, G. S. (2006) · Current Opinion in Anaesthesiology · doi:10.1097/01.aco.0000236137.23475.95 · Cited by 18
Dassie, E., Arcidiacono, D., Wasiak, I., Damiano, N., Dall’Olmo, L., Giacometti, C., Facchin, S., Cassaro, M., Guido, E., Lazzari, F. D., et al. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s86640 · Cited by 18 · cited 2×
“Cancer detection at early stages using NPs have been widely explored in recent years (Dassie et al., 2015).”
Qicai, L., Liu, Feng, Weng, Zhong, Liu, Lin, J., & Chen (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25842 · Cited by 14
Alamgir, W., & Haider, A. (2023) · Life and Science · doi:10.37185/lns.1.1.389 · Cited by 10
Nanopore‐Based Analysis of Chemically Modified DNA and Nucleic Acid Drug Targets
Larkin, J., Carson, S., Stoloff, D. H., & Wanunu, M. (2013) · Israel Journal of Chemistry · doi:10.1002/ijch.201300006 · Cited by 7 · cited 1×
“Nanopores have emerged as a new tool for studying the properties of nucleic acids at the single-molecule level (Larkin et al., 2013).”
Modeling Nanorobot Control Using Swarm Intelligence for Blood Vessel Repair: A Rigid-Tube Model
Kaewkamnerdpong, B., Boonrong, P., Trihirun, S., & Achalakul, T. (2015) · Adaptation, learning, and optimization · doi:10.1007/978-3-319-14400-9_10 · Cited by 3 · cited 1×
“In the treatment of atherosclerosis, it also can be used for the removal of blood clots, clean the wound, dispel parasites, remove kidney stones and artificial insemination (Biswas and Sen, 2016; Hariharan and Manohar, 2010; Kaewkamnerdpong et al., 2015).”
Curnis, F., Gasparri, A. M., Sacchi, A., Fiocchi, M., & Corti, A. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-4387 · Cited by 3 · cited 1×
“These findings support the concept that tagging tumor necrosis factor (TNF)-gold NPs with tumor vasculature homing peptides have improved antitumor activity, likely because of an active targeting mechanism (Curnis et al., 2015; England et al., 2013).”
Cited by
Drug Combinations in Breast Cancer Therapy
Fisusi, F. A., & Akala, E. O. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190122111224 · Cited by 449
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Recent Advances in Macrophage-Mediated Drug Delivery Systems
Liang, T., Zhang, R., Liu, X., Ding, Q., Wu, S., Li, C., Lin, Y., Ye, Y., Zhong, Z., & Zhou, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s298159 · Cited by 126
“However, existing polymer materials are not completely inert, which prevents their clinical application as drug carriers.(36) Therefore, macrophages have been used to replace polymer materials due to their potentially higher biocompatibility and ability to be fully metabolized into safe, non-toxic products.”
Background
Metadata
- Authors
- Su, H., Wang, Y., Gu, Y., Bowman, L., Zhao, J., & Ding, M.
- Venue
- Journal of Applied Toxicology
- Publisher
- Wiley
- Published
- 2017-06-06
- Volume
- 38
- Issue
- 1
- Pages
- 3-24
- ISSN
- 0260-437X (ISSN-L)
- 1099-1263
- OpenAlex
- W2621527800
- Cited by
- 178
- References
- 228
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.